153 related articles for article (PubMed ID: 32488227)
1. Pharmacogenomics: Current Actionable Variants.
González-Covarrubias V; Lozano K; Texis T; Guzmán-Cruz CK; Rodríguez-Dorantes M; Rubio-Carrasco K; Méndez-Lorenzo LH; Soberón X
Rev Invest Clin; 2020 May; 73(3):. PubMed ID: 32488227
[TBL] [Abstract][Full Text] [Related]
2. ADME Gene-Related Pharmacogenomic Labeling of FDA-Approved Drugs: Comparison with Clinical Pharmacogenetics Implementation Consortium (CPIC) Evidence Levels.
Deb S; Hopefl R; Reeves AA; Cvetkovic D
Medicines (Basel); 2024 Feb; 11(3):. PubMed ID: 38535119
[TBL] [Abstract][Full Text] [Related]
3. Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital.
Roberts TA; Wagner JA; Sandritter T; Black BT; Gaedigk A; Stancil SL
Clin Transl Sci; 2021 Jan; 14(1):412-421. PubMed ID: 33048453
[TBL] [Abstract][Full Text] [Related]
4. Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics data.
Kordou Z; Skokou M; Tsermpini EE; Chantratita W; Fukunaga K; Mushiroda T; Patrinos GP; Koromina M
Pharmacol Res; 2021 May; 167():105538. PubMed ID: 33705851
[TBL] [Abstract][Full Text] [Related]
5. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
Pritchard D; Patel JN; Stephens LE; McLeod HL
Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
[TBL] [Abstract][Full Text] [Related]
7. Prescription medications with actionable pharmacogenomic recommendations in Veterans Health Administration patients.
Maghari S; Gallo T; Rivas S; German A; Nguyen Le MQ; Abbaszadegan H; Zubriski MA; Heise CW; Landas ND
Pharmacogenomics; 2023 Jun; 24(9):501-508. PubMed ID: 37435738
[No Abstract] [Full Text] [Related]
8. Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation.
Bright D; Saadeh C; DeVuyst-Miller S; Sohn M; Choker A; Langerveld A
Pharmgenomics Pers Med; 2020; 13():719-724. PubMed ID: 33328756
[TBL] [Abstract][Full Text] [Related]
9. Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System.
Mroz P; Michel S; Allen JD; Meyer T; McGonagle EJ; Carpentier R; Vecchia A; Schlichte A; Bishop JR; Dunnenberger HM; Yohe S; Thyagarajan B; Jacobson PA; Johnson SG
Front Genet; 2021; 12():712602. PubMed ID: 34745204
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice.
Shahabi P; Dubé MP
Int J Cardiol; 2015 Apr; 184():772-795. PubMed ID: 25838112
[TBL] [Abstract][Full Text] [Related]
11. Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada.
Maruf AA; Shields M; Fryza A; Wondrasek A; Leong C; Kowalec K; Bousman C
Pharmacogenomics; 2024 Mar; 25(4):175-186. PubMed ID: 38506345
[No Abstract] [Full Text] [Related]
12. Primary Care Prescription Drug Use and Related Actionable Drug-Gene Interactions in the Danish Population.
Lunenburg CATC; Hauser AS; Ishtiak-Ahmed K; Gasse C
Clin Transl Sci; 2020 Jul; 13(4):798-806. PubMed ID: 32166845
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics in practice: a review and implementation guide.
Kabbani D; Akika R; Wahid A; Daly AK; Cascorbi I; Zgheib NK
Front Pharmacol; 2023; 14():1189976. PubMed ID: 37274118
[TBL] [Abstract][Full Text] [Related]
14. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
[TBL] [Abstract][Full Text] [Related]
15. Experience, Knowledge, and Perceptions of Pharmacogenomics among Pharmacists and Nurse Practitioners in Alberta Hospitals.
Hayashi M; Bousman CA
Pharmacy (Basel); 2022 Oct; 10(6):. PubMed ID: 36412815
[TBL] [Abstract][Full Text] [Related]
16. Fetal pharmacogenomics: A promising addition to complex neonatal care.
Raymond M; Critchlow E; Rice SM; Wodoslawsky S; Berger SI; Hegde M; Empey PE; Al-Kouatly HB
Mol Genet Metab; 2022; 137(1-2):140-145. PubMed ID: 36029725
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomic landscape of Indian population using whole genomes.
Sahana S; Bhoyar RC; Sivadas A; Jain A; Imran M; Rophina M; Senthivel V; Kumar Diwakar M; Sharma D; Mishra A; Sivasubbu S; Scaria V
Clin Transl Sci; 2022 Apr; 15(4):866-877. PubMed ID: 35338580
[TBL] [Abstract][Full Text] [Related]
18. Integrating pharmacogenomics into precision pain management.
Bates J; Fudin J; Patel JN
Support Care Cancer; 2022 Dec; 30(12):10453-10459. PubMed ID: 36271058
[TBL] [Abstract][Full Text] [Related]
19. How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT).
Li B; Sangkuhl K; Keat K; Whaley RM; Woon M; Verma S; Dudek S; Tuteja S; Verma A; Whirl-Carrillo M; Ritchie MD; Klein TE
Clin Pharmacol Ther; 2023 May; 113(5):1036-1047. PubMed ID: 36350094
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact.
Nunez-Torres R; Pita G; Peña-Chilet M; López-López D; Zamora J; Roldán G; Herráez B; Álvarez N; Alonso MR; Dopazo J; Gonzalez-Neira A
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]